Ellis Investment Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,066
Closed -$60K 265
2022
Q3
$60K Buy
4,066
+108
+3% +$1.79K 0.02% 364
2022
Q2
$65K Sell
3,958
-194
-5% -$3.33K 0.02% 368
2022
Q1
$83K Buy
4,152
+91
+2% +$1.89K 0.02% 346
2021
Q4
$103K Buy
+4,061
New +$105K 0.02% 317

Other funds holding BMEZ

Ellis Investment Partners's BMEZ Position: Q4 2022 in Review

Ellis Investment Partners sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2022, closing a stake of 4,066 shares — an estimated $60K sold.

Ellis Investment Partners first reported a position in BMEZ in Q4 2021 and held it in 4 quarters. The position peaked at $103K in Q4 2021. 82 funds tracked by Wall St. Rank hold BMEZ as of Q4 2022.

  • Ellis Investment Partners reported no remaining BlackRock Health Sciences Trust II position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 4,066 BlackRock Health Sciences Trust II shares in Q4 2022, an estimated $60K.
  • Ellis Investment Partners first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and held it in 4 quarters.
  • Ellis Investment Partners's BlackRock Health Sciences Trust II position peaked at $103K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.